Monoclonal antibody F16 I 124 - PhilogenAlternative Names: 124I-F16; 124I-F16SIP; F16-I-124; Iodine-124-labelled F-16 scFv antibody; Monoclonal antibody F-16-I-124; Tenapet
Latest Information Update: 16 Feb 2016
At a glance
- Originator Philogen
- Developer Philogen; VU University Medical Center
- Class Antineoplastics; Imaging agents; Monoclonal antibodies; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Solid tumours